Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 1 Pain 1 Neoplasms 1 Esophageal Neoplasms 1 Disease 1 Breast Neoplasms 1 Breakthrough Pain 1

Interventions

Cisplatin 161 Fluorouracil 135 Paclitaxel 127 Radiotherapy 125 Oxaliplatin 88 Docetaxel 71 Carboplatin 71 Irinotecan 60 pembrolizumab 57 Leucovorin 57 Capecitabine 57 Radiation 48 Esophagectomy 44 Surgical Procedures, Operative 41 Drug Therapy 38 Neoadjuvant Therapy 28 Cetuximab 25 Nivolumab 24 Bevacizumab 21 camrelizumab 20 Trastuzumab 20 S 1 (combination) 19 Chemoradiotherapy 19 Magnetic Resonance Spectroscopy 18 Epirubicin 16 Albumin-Bound Paclitaxel 16 Blood Specimen Collection 15 tislelizumab 14 Taxes 14 Radiotherapy, Intensity-Modulated 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Patient Positioning × Clear all

NCT02157363 2017-10-20

POETRI

Technische Universität Dresden

Phase NA Terminated

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡